End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.55 TWD | -0.26% | -2.74% | -22.73% |
04-15 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
03-21 | Applied BioCode Announces CEO Changes | CI |
Sales 2024 * | 430M 13.21M 1.06B | Sales 2025 * | - | Capitalization | 1.6B 49.1M 3.92B |
---|---|---|---|---|---|
Net income 2024 * | -145M -4.45M -356M | Net income 2025 * | - | EV / Sales 2024 * | 3.72 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
1 day | -0.26% | ||
1 week | -2.74% | ||
Current month | -9.07% | ||
1 month | -7.78% | ||
3 months | -14.63% | ||
6 months | -8.64% | ||
Current year | -22.73% |
Managers | Title | Age | Since |
---|---|---|---|
Zonh Zen Ho
CEO | Chief Executive Officer | - | 31/12/07 |
Liang Kai Huang
DFI | Director of Finance/CFO | - | 31/01/18 |
Cassandra Ingles
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
CHM | Chairman | 73 | 29/06/16 |
Benjamin Jen
BRD | Director/Board Member | 58 | 28/09/16 |
Wen Ching Tsai
BRD | Director/Board Member | - | 28/09/16 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 19.55 | -0.26% | 104,470 |
25/04/24 | 19.6 | -1.01% | 69,165 |
24/04/24 | 19.8 | +0.25% | 59,085 |
23/04/24 | 19.75 | -0.75% | 86,781 |
22/04/24 | 19.9 | -1.00% | 46,550 |
End-of-day quote Taiwan S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.73% | 49M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- 6598 Stock